Accessibility to targeted oncology drugs in Slovenia and selected European countries.
Accessibility to targeted oncology drugs in Slovenia and selected European countries.
Mitja Kos,M. Obradovic,A. Mrhar
2008 · DOI: 10.1016/J.EJCA.2007.11.020
European Journal of Cancer · 15 Citations
TLDR
The utilisation of targeted oncology drugs in Slovenia was in most cases lower than in comparison countries, except for alemtuzumab and rituximab.